ALLMedicine™ Alcoholic Hepatitis Center
Research & Reviews 670 results
https://clinicaltrials.gov/ct2/show/NCT03915002
Jun 30th, 2022 - In 2015, chronic liver diseases were responsible for approximately 2% of worldwide mortality and in 2016 cirrhosis and chronic liver diseases accounted for 531.1 age- standardized, Disability Adjusted Life Years (DALY's) /100,000 habitants.(1, 2) ...
https://doi.org/10.1080/17474124.2022.2090337
Expert Review of Gastroenterology & Hepatology; Lee DU, Chou H et. al.
Jun 17th, 2022 - In this study, we evaluate the clinical impact of psychiatric illnesses (PI) on the hospital outcomes of patients admitted with alcoholic liver disease (ALD). From the National Inpatient Sample from 2012-2017, patients with alcoholic cirrhosis or ...
https://doi.org/10.1002/hep.32604
Hepatology (Baltimore, Md.); Ma X, Chen A et. al.
Jun 15th, 2022 - Increased megamitochondria formation and impaired mitophagy in hepatocytes have been linked to the pathogenesis of alcohol-associated liver disease (ALD). This study aims to determine the mechanisms by which alcohol consumption increases megamitoc...
https://clinicaltrials.gov/ct2/show/NCT04563026
Jun 14th, 2022 - This is a randomized, double-blind, placebo-controlled, phase 2b clinical Trial evaluating Safety and Efficacy of DUR-928 (an experimental medication) in Patients with Alcoholic Hepatitis (AH).
https://clinicaltrials.gov/ct2/show/NCT05006430
Jun 6th, 2022 - Background: Alcoholic hepatitis (AH) is a major public health problem in the United States, caused by chronic alcohol consumption of more than 40-60 g/day. Approximately 5 million Americans are diagnosed with AH, contributing to 5% of US annual mo...
Guidelines 3 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524956
The American Journal of Gastroenterology; Singal AK, Bataller R et. al.
Jan 18th, 2018 - Alcoholic liver disease (ALD) comprises a clinical-histologic spectrum including fatty liver, alcoholic hepatitis (AH), and cirrhosis with its complications. Most patients are diagnosed at advanced stages and data on the prevalence and profile of ...
https://www.cghjournal.org/article/S1542-3565(16)30798-4/fulltext?code=yjcgh-site
Apr 17th, 2017 - The purpose of this clinical practice update is to review diagnostic criteria for severe acute alcoholic hepatitis and to determine the current best practices for this life-threatening condition. The best practices in this review are based on clin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287362
Gastroenterology Crabb DW, Bataller R et. al.
Feb 28th, 2016 - Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.|2016|Crabb DW,Bataller R,Chalasani NP,Kamath PS,Lucey M,|classification,standards,...
Clinicaltrials.gov 113 results
https://clinicaltrials.gov/ct2/show/NCT03915002
Jun 30th, 2022 - In 2015, chronic liver diseases were responsible for approximately 2% of worldwide mortality and in 2016 cirrhosis and chronic liver diseases accounted for 531.1 age- standardized, Disability Adjusted Life Years (DALY's) /100,000 habitants.(1, 2) ...
https://clinicaltrials.gov/ct2/show/NCT04563026
Jun 14th, 2022 - This is a randomized, double-blind, placebo-controlled, phase 2b clinical Trial evaluating Safety and Efficacy of DUR-928 (an experimental medication) in Patients with Alcoholic Hepatitis (AH).
https://clinicaltrials.gov/ct2/show/NCT05006430
Jun 6th, 2022 - Background: Alcoholic hepatitis (AH) is a major public health problem in the United States, caused by chronic alcohol consumption of more than 40-60 g/day. Approximately 5 million Americans are diagnosed with AH, contributing to 5% of US annual mo...
https://clinicaltrials.gov/ct2/show/NCT04106518
May 18th, 2022 - Alcoholic hepatitis carries a risk of high mortality at short term, especially in its severe form. Its diagnosis is confirmed by liver biopsy. The prevalence of alcoholic hepatitis, severe or not severe, is poorly known and prospective data are ne...
https://clinicaltrials.gov/ct2/show/NCT05018481
May 9th, 2022 - Written informed consent will be obtained during the baseline visit (day 1). Patients will given a physical exam and a blood test will be obtained if not in their medical chart. The subjects who meet the criteria after the screening visit will hav...
News 95 results
https://www.medscape.com/viewarticle/974654
Jun 1st, 2022 - Guidelines for the management of alcohol-related liver disease were published in April 2022 by the French Association for the Study of the Liver (AFEF) in Liver International.[1] Use the AUDIT-C questionnaire in general practice and specialist con...
https://www.medscape.com/viewarticle/974503
May 24th, 2022 - SAN DIEGO — Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.83% of those patients who received psychotherapy, counsel...
https://www.mdedge.com/internalmedicine/article/254812/hepatology/treatment-alcohol-abuse-reduces-hepatitis-readmission
Laird Harrison
May 22nd, 2022 - SAN DIEGO – Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.
https://www.medscape.com/viewarticle/971430
May 6th, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook. A worldwide ...
https://www.mdedge.com/gihepnews/article/253364/mixed-topics/celebrating-our-colleagues
Apr 1st, 2022 - In this month’s issue of GI & Hepatology News, we celebrate the recently named recipients of this year’s AGA Recognition Prizes, several of whom I am privileged to work with on a daily basis. We also welcome the newest members of AGA’s Governing B.